Biofrontera Inc. (BFRI) Return on equity 2020–2025
Biofrontera Inc. (BFRI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-100.5%FY2025 · since FY2020: -188.5% → -100.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -100.5% | +300.1 pp |
| FY2024 | -400.6% | +19.4 pp |
| FY2023 | -420.0% | -417.3 pp |
| FY2022 | -2.7% | +329.9 pp |
| FY2021 | -332.6% | -144.1 pp |
| FY2020 | -188.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BFRI financial trends
BFRI RevenueBFRI Net incomeBFRI Net marginBFRI Gross profitBFRI Gross marginBFRI Operating incomeBFRI Operating marginBFRI Operating cash flowBFRI Free cash flowBFRI Capital expendituresBFRI Stock buybacksBFRI Dividends paidBFRI Total assetsBFRI Total liabilitiesBFRI Shareholders’ equityBFRI overview →